Abbott (ABT) Tops Q2 EPS by 30c, Updates Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance
July 20, 2022 7:30 AM EDTSales growth of 10.1 percent; organic sales growth of 14.3 percentGAAP diluted EPS growth of 72.7 percent; adjusted diluted EPS growth of 22.2 percentGlobal COVID-19 testing-related sales of $2.3 billion in the second quarterContinues to strengthen portfolio with new product approvals
ABBOTT PARK, Ill., July 20, 2022 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2022.
Second-quarter sales of $11.3 billion increased 10.1 percent on a reported basis... More